Antineoplaston Therapy in Treating Patients With Stage IV Melanoma

Summary

Current therapies for Stage IV Melanoma provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Stage IV Melanoma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Stage IV Melanoma.

Timeline

Start

1996-03-27

Primary completion

2005-02-14

Completion

2005-02-14

Drugs

Indications